Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Simple One-Hour Saliva Test Detects Common Cancers

By LabMedica International staff writers
Posted on 09 Mar 2026

Early detection is critical for improving cancer outcomes, yet many diagnostic tests rely on invasive procedures such as blood draws or biopsies. More...

Researchers are exploring simpler approaches that could enable rapid screening using readily collected samples, such as saliva. Scientists have developed a new saliva-based test that detects a protein biomarker associated with several cancer types within approximately one hour.

Researchers at Queensland University of Technology (QUT; Brisbane, Australi) have developed a portable diagnostic method to detect the protein biomarker S100P, which has been linked to oral, colon, pancreatic, prostate, and several other cancers. The test uses a paper-based sensor coated with gold and silver nanoparticles. These particles enable a detection technique known as surface-enhanced Raman spectroscopy (SERS), which identifies molecules based on how they scatter laser light.

The researchers created a paper sensor that selectively captures the S100P biomarker from saliva samples. To prepare the sensor, antibodies were chemically attached to the nanoparticle-coated paper using a light-driven synthesis process with deep ultraviolet LEDs. Once the biomarker binds to the sensor, the system records the Raman spectrum of the sample, allowing detection of S100P without requiring complex laboratory processing. The team also developed a target-specific paper extraction chip that isolates the biomarker before analysis, improving detection accuracy. The resulting method, published in Talanta, provides a rapid and low-cost way to detect S100P using a saliva sample.

Because the test uses saliva rather than blood or tissue biopsies, it may offer a noninvasive screening approach that could potentially be used in point-of-care settings. The paper-based sensor also reduces manufacturing costs and avoids complex chemical processes typically used in biomarker detection. Researchers suggest that the technology could help identify cancers or precancerous changes earlier, allowing doctors to intervene sooner. Further studies will be required to validate the method before it can be implemented in clinical screening programs.

“This method could shorten diagnosis time to minutes instead of hours or days and uses low-cost and portable materials,” said Associate Professor Emad Kiriakous, PhD.

Related Links:
Queensland University of Technology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.